• Tue, September 10, 2024

Silvan Tuerkcan Maintained (TERN) at Buy with Increased Target to $20 on, Sep 10th, 2024

Silvan Tuerkcan of JMP Securities, Maintained "Terns Pharmaceuticals, Inc." (TERN) at Buy with Increased Target from $15 to $20 on, Sep 10th, 2024.

Silvan has made no other calls on TERN in the last 4 months.



There are 2 other peers that have a rating on TERN. Out of the 2 peers that are also analyzing TERN, 1 agrees with Silvan's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Ed Arce of "HC Wainwright & Co." Reiterated at Hold and Held Target at $5.5 on, Tuesday, May 14th, 2024


This is the rating of the analyst that currently disagrees with Silvan


  • Etzer Darout of "BMO Capital" Reiterated at Buy and Held Target at $19 on, Tuesday, August 6th, 2024